Breast cancer and sexuality: Multi-modal treatment options

Journal of Sexual Medicine

Volumn 9, Issue 1, 2012, Pages 5-13

  Krychman, Michael L ^a   Katz, Anne ^b  

^a Southern California Center   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast Cancer; Female Sexual Dysfunction; Medications; Mindfulness; Psychosocial

Indexed keywords

AMFEBUTAMONE; ANASTROZOLE; ANDROGEN; AROMATASE INHIBITOR; BREMELANOTIDE; ESTRADIOL; LUBRICATING AGENT; OSPEMIFENE; PHOSPHODIESTERASE V INHIBITOR; PRASTERONE; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TESTOSTERONE;

ANDROGEN THERAPY; AROMATIZATION; ARTICLE; BODY IMAGE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVOR; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; HOT FLUSH; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; LIBIDO DISORDER; LONG TERM CARE; MARITAL THERAPY; MULTIMODALITY CANCER THERAPY; ORGASM; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SELF CONCEPT; SELF ESTEEM; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL SATISFACTION; SYSTEMIC THERAPY; TREATMENT DURATION; TUMOR CELL; VAGINA ATROPHY; VAGINA RING; VAGINAL DRYNESS;

EID: 84855354998     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02566.x     Document Type: Article

References (52)

1. Col NF, Kim JA, Chlebowski RT. Menopausal hormone replacement therapy after breast cancer: A meta-analysis and critical appraisal of the evidence. Breast Cancer Res 2005;7:R535-40.
2. Pritchard KI, Khan H, Levine M. Clinical practice guideline for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer. CMAJ 2002;166:1017-22.
3. Society of Obstetricians and Gynaecologists of Canada. Use of hormonal replacement therapy after treatment of breast cancer. Number 142, May 2004. Int J Gynaecol Obstet 2005;88:216-21.
4. North American Menopause Society. The role of local estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement on the North American Menopause Society. Menopause 2007;14:355-69.
5. Pruthi S, Simon JA, Early AP. Current overview of the management of urogenital atrophy in women with breast cancer. Breast J 2011;17:403-8.
6. Sturdee DW, Panay N, International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509-22. Epub September 30, 2010.
7. Kendal A, Dowsett M, Folkerd E, Smith I. Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjunct aromatase inhibitors. Ann Oncol 2006;17:584-7.
8. Memorial Sloan-Kettering Cancer Center Clinical Trial. Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen. 2010. Available at: (accessed September 26, 2010).
9. Gennari L. Ospemifene hormos. Curr Opin Investig Drugs 2004;5:448-55.
10. Rutanen E, Heikkinen J, Halonen K, Komi J, Lammintausta R, Ylikorkala O. Effects of ospemifene, a novel SERM, on hormones genital tract, climacteric symptoms and quality of life in postmenopausal women: A double-blind randomized trial. Menopause 2004;10:433-9.
11. Bachmann GA, Komi J, Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study. Menopause 2010;17:480-6.
12. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 2009;16:907-22.
13. Witherby S, Johnson J, Demers L, Mount S, Littenberg B, Maclean CD, Wood M, Muss H. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: A phase I/II study. Breast Cancer Res Treat 2007;106(1 suppl): S276. Abstract 6086.
14. Vaginal testosterone cream for atrophic vaginitis in women taking aromatase inhibitors for breast cancer. NCT01122342. Available at: (accessed November 7, 2011).
15. Barton D, Wender D, Sloan J, Dalton R, Balcueva E, Atherton P, Bernath Jr A, DeKrey W, Larson T, Bearden III J, Carpenter P, Loprinizi C. Randomized clinical trial to evaluate transdermal testosterone in female cancer survivors with decreased libido. North Central Cancer Treatment Group Protocol N02C3. J Natl Cancer Inst 2007;99:672-8.
16. Krychman ML, Stelling CJ, Carter J, Hudis CA. A case series of androgen use in breast cancer survivors with sexual dysfunction. J Sex Med 2007;4:1769-74.
17. Derko C, Elliott S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 2007;14(1 suppl):S20-40.
18. Snabes M, etal. Libigel Clinical Trial Update. Poster Presentation at the North American Menopause Society Chicago, 2010.
19. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keler A, McGarvey EL. A placebo controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor induced sexual dysfunction. J Clin Psychiatry 2004;65:62-7.
20. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. Clin Ther 2007;29:230-41.
21. Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Weinshilboum RM, Fritcher EG, Nibbe AM, Desta Z, Nguyen A, Flockhart DA, Perez EA, Ingle JN. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 2007;101:113-21.
22. Rae JM, Drury S, Hayes DF, Stearns V, Thibert JN, Haynes BP, Salter J, Pineda S, Cuzick J, Dowsett M, University of Michigan, Ann Arbor; University of Michigan; Royal Marsden Hospital, United Kingdom; Breakthrough Breast Cancer Research Centre, United Kingdom; Johns Hopkins University; CRUK Centre for Epidemiology, Mathematics and Statistics, United Kingdom. 2010 Lack of correlation between gene variants in tamoxifen metabolizing enzymes with primary endpoints in the ATAC trial [abstract S1-7]. Abstract presented at: 33rd Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 8-12, 2010.
23. Leyland-Jones B, Regan MM, Bouzyk M, Kammler R, Tang W, Pagani O, Maibach R, Dell'Orto P, Thürlimann B, Price KN, Viale G. BIG 1-98 Collaborative Group and International Breast Cancer Study Group, Bern, Switzerland. 2010 Outcome according to CYP 2D6 genotype among postmenopausal women with endocrine-responsive early invasive breast cancer randomized in the BIG 1-98 Trial [abstract S1-8]. Abstract presented at: 33rd Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 8-12, 2010.
24. Hong L, Wu K, Fan D. Sildenafil as treatment for antidepressant-induced sexual dysfunction. JAMA 2008;300:2365, author reply 2365-6.
25. Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: A double-blind placebo-controlled, fixed dose, randomized study. J Sex Med 2008;5:887-97.
26. American College of Obstetricians and Gynecologists Task Force on Hormone Therapy. Sexual dysfunction. Obstet Gynecol 2004;104:85S-91S.
27. Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004. Int J Gynaecol Obstet 2005;88:222-8.
28. Kingsberg SA, Kellogg S, Krychman M. Treating dyspareunia caused by vaginal atrophy: A review of treatment options using vaginal estrogen therapy. Int J Women's Health 2009;2:1-6.
29. Carter J, Goldfrank D, Schover L. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 2011;8:549-59.
30. Lee YK, Chung HH, Kim JW, Park NH, Song YS, Kang SB. Vaginal pH balanced gel for the control of atrophic vaginitis among breast cancer survivors. Obstet Gynecol 2011;117:922-7.
31. Hutcherson H, Kingsberg S, Krychman M, Schwartz P, Leiblum S, Rosen R, Althof S. A positive approach to female sexual health: A summary report. Female Patient 2009;34(4 Suppl 2):S1-6.
32. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of uro-genital atrophy in postmenopausal women: Second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-7.
33. Ito TY, Trant AS, Polan ML. Double blind placebo controlled study of arginimax, a nutritional supplement for enhancement of female sexual function. J Sex Marital Ther 2001;27:541-9.
34. Krychman ML, Kellogg Spadt S. Sexuality and breast cancer. Coping magazine. Media America Inc, Franklin TN: Media America Inc Publishing; 2009:20.
35. Dizon D. Quality of life after breast cancer: Survivorship and sexuality. Breast J 2009;15:500-4.
36. Scott J, Kayser K. A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J 2009;15:48-56.
37. Christensen D. Postmastectomy couple counseling: An outcome study of a structured treatment protocol. J Sex Marital Ther 1983;9:266-75.
38. Baucom D, Porter L, Kirby J, Gremore T, Wiesenthal N, Aldridge W, Fredman S, Stanton S, Scott J, Halford K, Keefe F. A couple-based intervention for female breast cancer. Psychooncology 2009;18:276-83.
39. Scott J, Halford K, Ward B. United we stand? The effects of a couple-coping intervention on adjustment to early stage breast or gynecological cancer. J Consult Clin Psychol 2004;72:1122-35.
40. Kalaitzi C, Papadopoulos V, Michas K, Vlasis K, Skandalakis P, Fillipou D. Combined brief psychosexual intervention after mastectomy: Effects on sexuality, body image, and psychological well-being. J Surg Oncol 2007;96:235-40.
41. Rowland J, Meyerowitx B, Crespi C, Leedham B, Desmond K, Belin T, Ganz P. Addressing intimacy and partner communication after breast cancer: A randomized controlled group intervention. Breast Cancer Res Treat 2009;118:99-111.
42. Jun E, Kim S, Chang S, Oh K, Kand H, Kang S. The effect of a Sexual Life Reframing program on marital intimacy, body image, and sexual function among breast cancer survivors. Cancer Nurs 2011;34:142-9.
43. Duijts S, Oldenburg H, van Beurden M, Aaronson N. Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: Design of a multi-center study, BMC Women's Health2009. Available at: (accessed November 7, 2011).
44. Herbenick D, Reece M, Hollub A, Satinsky S, Dodge B. Young female breast cancer survivors. Their sexual function and interest in sexual enhancement products and services. Cancer Nurs 2008;31:417-25.
45. Lengacher C, Reich R, Post-White J, Moscoso M, Shelton M, barta M, Budhrani P. Mindfulness based stress reduction in post-treatment breast cancer patients: An examination of symptoms and symptom clusters. J Behav Med 2011 Apr 20. [Epub ahead of print] doi: 10.1007/s10865-011-9346-4.
46. Lengacher C, Johnson-Mallard V, Post-White J, Moscoso M, Jacobsen P, Klein T, Widen R, Fitzgerald S, Shelton M, Barta M, Goodman M, Cox C, Kip K. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 2009;18:1261-72.
47. Lengacher C, Johnson-Mallard V, Barta M, Fitzgerald S, Moscoso M, Post-White J, Jacobsen P, Shelton M, Le N, Budhrani P, Goodman M, Kip K. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs 2011;29:107-17.
48. Kvillemo P, Branstrom R. Experiences of a mindfulness-based stress-reduction intervention among patients with cancer. Cancer Nurs 2011;34:24-31.
49. Foley E, Baillie A, Huxter M, Price M, Sinclair E. Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: A randomized controlled trial. J Consult Clin Psychol 2010;78:72-9.
50. Tacon A, Caldera Y, Ronaghan C. Mindfulness-based stress reduction in women with breast cancer. Fam Syst Health 2004;22:193-203.
51. Brotto L, Basson R, Luria M. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J Sex Med 2008;5:1646-59.
52. Brotto L, Heiman J. Mindfulness in sex therapy: Applications for women with sexual difficulties following gynecological cancer. Sex Relat Therapy 2007;22:3-11.